Older Americans worried about cognitive decline can stay sharper for longer by exercising both their bodies and their brains ...

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...

GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...

Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...

Through treating people’s obesity and their type 2 diabetes, through drugs like Ozempic, we may be able to eliminate a ...

Could weight loss drugs like Ozempic help combat addiction? STAT explores the question in our weekly video series.

Some popular weight loss drugs — such as Ozempic, Mounjaro and Wegovy — may lower the risk of dementia and stroke for patients with Type 2 diabetes and obesity, new research suggests.

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper generic copycats ...

A new study suggests that popular diabetes and weight-loss medications like Ozempic and Mounjaro may help protect against brain-related diseases such as dementia and stroke.